FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308174577> ?p ?o ?g. }

• W4308174577 endingPage "10" @default.
• W4308174577 startingPage "1" @default.
• W4308174577 abstract "Benefits of adjuvant radiotherapy (ART) after gross-total resection (GTR) of de novo atypical meningiomas (AMs) are controversial, and factors predictive of radiotherapy benefits in patients with de novo AMs after GTR are unknown. The authors aimed to evaluate the benefits of ART and explore potential factors sensitizing AMs to ART.A total of 231 consecutive patients who were pathologically diagnosed with de novo AMs and treated with GTR (Simpson class I-III resections) from 2010 to 2018 were enrolled in the study. Clinicopathological and prognostic information was collected and analyzed. Univariate and multivariate Cox analyses were used to evaluate prognostic predictors and compare the response to radiotherapy. Propensity score matching (PSM) was used to balance the confounding bias in subgroups.A total of 138 patients (59.74%) received ART. Progesterone receptor (PR) expression was positive in 157 patients (67.97%). During the mean follow-up period of 76.25 months, 65 patients (28.14%) experienced recurrence and 38 (16.45%) died of tumor progression. For disease-specific survival (DSS), ART was a better prognostic factor via univariate (p = 0.003) and multivariate (p = 0.025) analyses. For progression-free survival (PFS), univariate Cox analysis showed that ART improved PFS (p = 0.013), but multivariate analysis did not (p = 0.068). Positive PR expression (p = 0.019), age 53.5 years or younger (p = 0.012), and Ki-67 7.5% or lower (p = 0.025) were independent prognostic predictors for better PFS. In the subcohort analysis, the beneficial impact of ART was observed in the PR-negative cohort (p = 0.002) but not in the PR-positive cohort (p = 0.86). The heterogeneity analysis demonstrated that the PR-negative cohort was more sensitive to ART than the PR-positive cohort (p = 0.036). ART was not found to be associated with better PFS in younger patients (≤ 53.5 years, p = 0.14), older patients (> 53.5 years, p = 0.085), those with a Ki-67 index ≤ 7.5% (p = 0.068), or those with a Ki-67 > 7.5% (p = 0.13). The contrasting effects of ART in the PR-negative versus PR-positive cohorts remained true even after PSM, confirming that PR-negative, but not PR-positive, de novo AMs benefited from ART after GTR.ART was an independent prognostic factor for DSS of patients with de novo AMs treated with GTR (p = 0.025), but not for PFS (p = 0.068). Negative PR expression was a radiosensitive biomarker on PFS for de novo AM patients after GTR." @default.
• W4308174577 created "2022-11-08" @default.
• W4308174577 creator A5006633218 @default.
• W4308174577 creator A5010224849 @default.
• W4308174577 creator A5028225823 @default.
• W4308174577 creator A5028528726 @default.
• W4308174577 creator A5033427573 @default.
• W4308174577 creator A5036035882 @default.
• W4308174577 creator A5040427473 @default.
• W4308174577 creator A5057342168 @default.
• W4308174577 creator A5090533727 @default.
• W4308174577 date "2022-11-01" @default.
• W4308174577 modified "2023-10-16" @default.
• W4308174577 title "Progesterone receptor expression and prediction of benefits of adjuvant radiotherapy in de novo atypical meningiomas after gross-total resection" @default.
• W4308174577 cites W1982831344 @default.
• W4308174577 cites W1995830991 @default.
• W4308174577 cites W2013224015 @default.
• W4308174577 cites W2014888603 @default.
• W4308174577 cites W2016757970 @default.
• W4308174577 cites W2021899144 @default.
• W4308174577 cites W2025619919 @default.
• W4308174577 cites W2036069785 @default.
• W4308174577 cites W2039838946 @default.
• W4308174577 cites W2060724712 @default.
• W4308174577 cites W2097267553 @default.
• W4308174577 cites W2118328286 @default.
• W4308174577 cites W2123670663 @default.
• W4308174577 cites W2131246176 @default.
• W4308174577 cites W2149060599 @default.
• W4308174577 cites W2149794835 @default.
• W4308174577 cites W2152959057 @default.
• W4308174577 cites W2225929636 @default.
• W4308174577 cites W2366536035 @default.
• W4308174577 cites W2514454733 @default.
• W4308174577 cites W2515148019 @default.
• W4308174577 cites W2600035543 @default.
• W4308174577 cites W2607616395 @default.
• W4308174577 cites W2766742383 @default.
• W4308174577 cites W2768096089 @default.
• W4308174577 cites W2783673415 @default.
• W4308174577 cites W2803832675 @default.
• W4308174577 cites W2806811929 @default.
• W4308174577 cites W2884129176 @default.
• W4308174577 cites W2893815825 @default.
• W4308174577 cites W2912021674 @default.
• W4308174577 cites W2914257505 @default.
• W4308174577 cites W2947909890 @default.
• W4308174577 cites W3008126322 @default.
• W4308174577 cites W3040059694 @default.
• W4308174577 cites W3047645162 @default.
• W4308174577 cites W3119782215 @default.
• W4308174577 cites W3174246647 @default.
• W4308174577 cites W3197731958 @default.
• W4308174577 cites W4200099986 @default.
• W4308174577 cites W4200327950 @default.
• W4308174577 cites W4206403394 @default.
• W4308174577 cites W4211033536 @default.
• W4308174577 doi "https://doi.org/10.3171/2022.9.jns221530" @default.
• W4308174577 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36334291" @default.
• W4308174577 hasPublicationYear "2022" @default.
• W4308174577 type Work @default.
• W4308174577 citedByCount "0" @default.
• W4308174577 crossrefType "journal-article" @default.
• W4308174577 hasAuthorship W4308174577A5006633218 @default.
• W4308174577 hasAuthorship W4308174577A5010224849 @default.
• W4308174577 hasAuthorship W4308174577A5028225823 @default.
• W4308174577 hasAuthorship W4308174577A5028528726 @default.
• W4308174577 hasAuthorship W4308174577A5033427573 @default.
• W4308174577 hasAuthorship W4308174577A5036035882 @default.
• W4308174577 hasAuthorship W4308174577A5040427473 @default.
• W4308174577 hasAuthorship W4308174577A5057342168 @default.
• W4308174577 hasAuthorship W4308174577A5090533727 @default.
• W4308174577 hasConcept C105795698 @default.
• W4308174577 hasConcept C126322002 @default.
• W4308174577 hasConcept C143998085 @default.
• W4308174577 hasConcept C144301174 @default.
• W4308174577 hasConcept C161584116 @default.
• W4308174577 hasConcept C17923572 @default.
• W4308174577 hasConcept C199163554 @default.
• W4308174577 hasConcept C2777863537 @default.
• W4308174577 hasConcept C2780739268 @default.
• W4308174577 hasConcept C3018454096 @default.
• W4308174577 hasConcept C3019894029 @default.
• W4308174577 hasConcept C33923547 @default.
• W4308174577 hasConcept C38180746 @default.
• W4308174577 hasConcept C50382708 @default.
• W4308174577 hasConcept C509974204 @default.
• W4308174577 hasConcept C71924100 @default.
• W4308174577 hasConcept C77350462 @default.
• W4308174577 hasConceptScore W4308174577C105795698 @default.
• W4308174577 hasConceptScore W4308174577C126322002 @default.
• W4308174577 hasConceptScore W4308174577C143998085 @default.
• W4308174577 hasConceptScore W4308174577C144301174 @default.
• W4308174577 hasConceptScore W4308174577C161584116 @default.
• W4308174577 hasConceptScore W4308174577C17923572 @default.
• W4308174577 hasConceptScore W4308174577C199163554 @default.
• W4308174577 hasConceptScore W4308174577C2777863537 @default.
• W4308174577 hasConceptScore W4308174577C2780739268 @default.

• next